Greg Meyers, chief digital and technology officer at Bristol Myers Squibb, explains how AI is transforming pharmaceutical research from hypothesis-driven hunches to data-driven discoveries. Learn how the company is using computational chemistry to engineer breakthrough therapies like a sickle cell treatment heading to human trials, and why they built internal AI tools for 25,000+ employees. Learn more at ai-podcast.nvidia.com.
- Coach for SpaceX & OpenAI destroys your limiting beliefs for 88 minutes straight
- 687. Are Prediction Markets the Best Forecasting Tool Ever — or Just Another Casino?
- He Warned AI Could Destroy Us. Now The Industry Is Listening — ft. Nick Bostrom
- The Week: China’s Upper Hand, a Troubled Bond Market, and a New Mortgage Crisis
- Most Replayed Moment: Is Renting Keeping You Poor? What’s The Actual Cost Of Home Ownership? David Bach